Editor's note: The bio-industry is a strategic emerging industry that is having a major impact on human health, food, ecological environment, and sustainable development. Recently, Global Industry Analysts Inc. (GIA) released a comprehensive report on the global biotechnology instrument market, showing that the global biotechnology instrument market is expected to reach US$5.8 billion by 2015.
Grabbing the commanding heights of the global economy, the bio-industry has become one of the fastest growing industrial sectors in the world. Global bio-industry sales have doubled almost every five years, and the growth rate is 10 times the average growth rate of the world economy. Many developed countries and newly industrialized countries in the world have adopted the bio-industry as the strategic choice for the post-financial crisis era to promote sustainable economic and social development and to seize the commanding heights of the world's economic and technological fields.
The United States is currently the world's largest market for biotech equipment, followed by the European market. However, due to the economic expansion of China and India, the Asia Pacific region is the fastest growing market for biotech equipment. In addition, biotechnology, specialty chemicals, electronic products, pharmaceuticals and other industries are gradually shifting to high-tech fields, and high-performance liquid chromatography equipment and supplies have become the most demanding segmented products in this market. In addition, researchers are now more and more inclined to understand the instrument and the rapidity of the system. Therefore, the programmability of mass spectrometry and the automation of liquid chromatography (simplification of chromatographic operating procedures) will be the market demand in the next few years. . Electrophoretic equipment and supplies have become the fastest growing subdivided products in this market; DNA sequencing products rank second, and their demand is expected to increase by 3.5%.
According to the introduction of SMEs, the development of the global bio-industry is divided into three stages: the initial stage is 1980-2000, the growth stage is 2000-2010, and the mature stage will be after 2015. The world's bio-industry is currently in the transitional period between initial stage and rapid growth stage, and the monopoly structure controlled by a few multinational corporations has not yet formed. Compared with advanced countries in the world, the technology, talents, and foundation of China's bio-industry are among the lowest in the high-tech field, and are rich in biological resources. They are the fields that are most hopeful for leap-forward development.
As early as ten years ago, in the pharmaceutical research, the development of proteomics and the need for high-throughput technologies, instruments and equipment became more and more an organic part of the laboratory, all of which promoted the development of the bio-instrument industry, but with it The maturation of the market has made the survival of those smaller companies more difficult. Since each market sector has a leading company that occupies a relatively large market share in this sector, it is difficult for smaller companies to enter these areas. For these companies, the difficulty lies in the lack of visibility of more powerful and well-known companies.
Chaoyang industry has broad prospects but it is undeniable that compared with the international level, there is still a gap in most areas of the biological industry in China. The director of the Chinese Society for Biological Engineering and the academician of the Chinese Academy of Engineering pointed out that the biggest gap in the field of biomedicine in China is that there are too few original drugs, and 97% are generic drugs. Most of the current products are products that have expired patents with very thin profits. . In the future, the development of China's bio-industry will focus on four major areas, namely bio-pharmaceuticals, bio-agriculture, medical devices, and bio-industry, also known as bio-manufacturing.
It is understood that the “Twelfth Five-Year†bio-industry plan led by the National Development and Reform Commission has begun to solicit social opinions. The National Development and Reform Commission and related departments have carried out relevant research work to promote the development of the bio-industry from many aspects such as the direction of technological innovation in bio-industries, major tasks in industrialization and industrial development, industrial layout, market cultivation, personnel training, fiscal and taxation policies, and investment and financing policies. .
This is undoubtedly a great advantage for companies in this area. Relevant persons pointed out that the integration of bio-industries into strategic emerging industries means that the bio-industries will usher in more national policies and financial support, and related listed companies will also benefit from them.
It is estimated that by 2020, China’s broad-based bio-industry market will reach 6 trillion yuan, of which the generalized bio-pharmaceutical market will be 4 trillion yuan, bio-manufacturing 1 trillion yuan, bio-agricultural 500 billion yuan, and bio-energy 300 billion yuan. Biological environmental protection is about 100 billion yuan. In the future, China's biotechnology companies will face greater opportunities and challenges.
Grabbing the commanding heights of the global economy, the bio-industry has become one of the fastest growing industrial sectors in the world. Global bio-industry sales have doubled almost every five years, and the growth rate is 10 times the average growth rate of the world economy. Many developed countries and newly industrialized countries in the world have adopted the bio-industry as the strategic choice for the post-financial crisis era to promote sustainable economic and social development and to seize the commanding heights of the world's economic and technological fields.
The United States is currently the world's largest market for biotech equipment, followed by the European market. However, due to the economic expansion of China and India, the Asia Pacific region is the fastest growing market for biotech equipment. In addition, biotechnology, specialty chemicals, electronic products, pharmaceuticals and other industries are gradually shifting to high-tech fields, and high-performance liquid chromatography equipment and supplies have become the most demanding segmented products in this market. In addition, researchers are now more and more inclined to understand the instrument and the rapidity of the system. Therefore, the programmability of mass spectrometry and the automation of liquid chromatography (simplification of chromatographic operating procedures) will be the market demand in the next few years. . Electrophoretic equipment and supplies have become the fastest growing subdivided products in this market; DNA sequencing products rank second, and their demand is expected to increase by 3.5%.
According to the introduction of SMEs, the development of the global bio-industry is divided into three stages: the initial stage is 1980-2000, the growth stage is 2000-2010, and the mature stage will be after 2015. The world's bio-industry is currently in the transitional period between initial stage and rapid growth stage, and the monopoly structure controlled by a few multinational corporations has not yet formed. Compared with advanced countries in the world, the technology, talents, and foundation of China's bio-industry are among the lowest in the high-tech field, and are rich in biological resources. They are the fields that are most hopeful for leap-forward development.
As early as ten years ago, in the pharmaceutical research, the development of proteomics and the need for high-throughput technologies, instruments and equipment became more and more an organic part of the laboratory, all of which promoted the development of the bio-instrument industry, but with it The maturation of the market has made the survival of those smaller companies more difficult. Since each market sector has a leading company that occupies a relatively large market share in this sector, it is difficult for smaller companies to enter these areas. For these companies, the difficulty lies in the lack of visibility of more powerful and well-known companies.
Chaoyang industry has broad prospects but it is undeniable that compared with the international level, there is still a gap in most areas of the biological industry in China. The director of the Chinese Society for Biological Engineering and the academician of the Chinese Academy of Engineering pointed out that the biggest gap in the field of biomedicine in China is that there are too few original drugs, and 97% are generic drugs. Most of the current products are products that have expired patents with very thin profits. . In the future, the development of China's bio-industry will focus on four major areas, namely bio-pharmaceuticals, bio-agriculture, medical devices, and bio-industry, also known as bio-manufacturing.
It is understood that the “Twelfth Five-Year†bio-industry plan led by the National Development and Reform Commission has begun to solicit social opinions. The National Development and Reform Commission and related departments have carried out relevant research work to promote the development of the bio-industry from many aspects such as the direction of technological innovation in bio-industries, major tasks in industrialization and industrial development, industrial layout, market cultivation, personnel training, fiscal and taxation policies, and investment and financing policies. .
This is undoubtedly a great advantage for companies in this area. Relevant persons pointed out that the integration of bio-industries into strategic emerging industries means that the bio-industries will usher in more national policies and financial support, and related listed companies will also benefit from them.
It is estimated that by 2020, China’s broad-based bio-industry market will reach 6 trillion yuan, of which the generalized bio-pharmaceutical market will be 4 trillion yuan, bio-manufacturing 1 trillion yuan, bio-agricultural 500 billion yuan, and bio-energy 300 billion yuan. Biological environmental protection is about 100 billion yuan. In the future, China's biotechnology companies will face greater opportunities and challenges.
Two Wheel Electric Vehicle,Electric Tricycle Trike,Enclosed Electric Tricycle,Street Bike Motorcycle
FengXian Enland International Trading Co.,LTD , https://www.jsenland.com